Buscar
Mostrando ítems 1-10 de 49
Utilidad clínica del factor reumatoíde en el líquido sinovial. Reevaluación
(1993)
The aim of this work is to analyze the usefulness of rheumatoid factor determination in synovial fluid. One hundred twenty nine patients (29 with rheumatoid arthritis), in whom rheumatoid factor was simultaneously determined ...
Rheumatoid factor as predictor of response to treatment with anti-TNF alpha drugs in patients with rheumatoid arthritis
(Wolters Kluwer Health, Inc.Estados Unidos, 2019-02)
We determined whether rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (ACPA) can predict remission or severe
disability in rheumatoid arthritis (RA) patients treated with anti-tumor necrosis factor ...
Desenlaces clínicos en artritis reumatoidea tratada con infliximab: Hospital de San José, 2007-2008
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2009-09-01)
Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid arthritis in low-disease activity: persistent benefits. Data from the Corrona registry
(BMJ Publishing Group, 2015)
Background There is increasing interest in discontinuing biological therapies for patients with rheumatoid arthritis (RA) achieving good clinical responses, provided patients maintain clinical benefit.
Methods We ...
Therapeutic effects of the anti-tumor necrosis factor monoclonal antibody, infliximab, in four children with refractory juvenile idiopathic arthritis
(Elsevier Doyma, 2007)
Objective: To report the results of treatment with infliximab in patients with refractory juvenile idiopathic arthritis (JIA). Patients and methods: A prospective study of four children with refractory JIA was carried out. ...
Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
(International League of Associations for Rheumatology (ILAR), 2014)
Tumor necrosis factor (TNF) plays a pivotal role in
the pathogenesis of rheumatoid arthritis (RA). This finding
has led to the development of TNF blockers for RA treatment.
However, response to these therapies is ...
Papel de los polimorfismos -238 y -308 del promotor del factor de necrosis tumoral alfa en la patogenia y respuesta al tratamiento anti- factor de necrosis tumoral alfa en artritis reumatoide
(Sociedad Médica de Santiago, 2005)
Rheumatoid arthritis (RA) is a systemic autoimmune disease that
affects 0.8% of the world population, it affects the synovial membrane of joints and the clinical
presentation encompasses a wide spectrum, ranging from a ...
TNF-alpha affects signature cytokines of th1 and th17 t cell subsets through differential actions on TNFR1 and TNFR2
(MDPI, 2022)
Tumor necrosis factor (TNF)- is a pleiotropic cytokine implicated in the etiology of
several autoimmune diseases, including rheumatoid arthritis (RA). TNF- regulates diverse effector
functions through the activation ...